Insider Transactions in Q4 2022 at Caribou Biosciences, Inc. (CRBU)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2022
|
Steven Kanner Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,401
+6.21%
|
$42,802
$2.69 P/Share
|
|
Oct 06
2022
|
Ryan Fischesser VP of Finance and Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
5,678
+2.42%
|
$17,034
$3.4 P/Share
|
|
Oct 06
2022
|
Ryan Fischesser VP of Finance and Controller |
SELL
Open market or private sale
|
Direct |
10,000
-8.31%
|
$100,000
$10.8 P/Share
|